Cancer Genomics Testing
Cancer Genomics is the study of gene mutations that may be driving a cancer’s behavior. These tests are critical in finding your risk factor to certain cancers as well as helping establish preventative care plans.
Common Hereditary Cancers and Cancer Syndromes:
- P Breast, Ovarian, Endometrial, Uterine Cancer (BRCA1, BRCA2)
- P Colon, Renal, Pancreatic, Gastric, Liver Cancer(APC, BMPR1A, EPCAM)
- P Lynch Syndrome (MLH1, MSH2, MSH6, PMS2, EPCAM)
- P Prostate Cancer (BRCA1, BRAC2, EPCAM, MLH1, MSH2, MSH6, NBN, PMS2, STK11)
- P Pancreatic Cancer (APC,ATM, BMPR1A, BRCA1, BRCA2, CDKN2A, EPCAM, MLH1, MSH2, MSH6, PALB2, PMS2, RINT1, STK11,SMAD4, TP53,VHL,XRCC2)
- P Melanoma Cancer (BRCA1, BRCA2, CDKN2A, EPCAM, MLH2, MSH2, PTEN, TP53)
Who qualifies for hereditary cancer testing?
- An individual who has or had, more than one cancer.
- An individual with a personal history of cancer with limited availability of family history and single-gene testing has not found a mutation, or the result is uncertain.
- An individual who has multiple close family members with a cancer diagnosis under the age of 50.
- An individual with family members who have taken a cancer genetic test and mutations were identified.
- An individual being a member of a racial or ethnic group that is known to have an increased risk of having a certain inherited cancer susceptibility syndrome.
- An individual with a personal or family history of cancer and single-gene testing has not found a mutation, or unclear results.
- An individual with rare or unusual cancer presentations.